Dr. Lopes da Silva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Dr
Bethesda, MD 20814
Summary
- Dr. Laercio DaSilva is a Medical Oncology Fellow at the National Cancer Institute in Bethesda, MD.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
MetroWest Medical CenterResidency, Internal Medicine, 2019 - 2022
Faculty Of Medical Sciences of Santa Casa De Sao PauloClass of 2014
Certifications & Licensure
DC State Medical License 2022 - 2024
MA State Medical License 2019 - 2022
Publications & Presentations
PubMed
- 42 citationsTreatment-Related Adverse Events of Combination Immune Checkpoint Inhibitors: Systematic Review and Meta-AnalysisRobin Park, Laercio Lopes, Cagney Cristancho, Ivy Riano, Anwaar Saeed
Frontiers in Oncology. 2020-03-17 - 26 citationsAnti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysisRobin Park, Laercio Lopes, Azhar Saeed
Clinical & Translational Oncology. 2021-01-01 - 16 citationsOutcomes following immunotherapy re-challenge after immune-related adverse event: systematic review and meta-analysis.Robin Park, Laercio Lopes, Anwaar Saeed
Immunotherapy. 2020-09-03
Journal Articles
- The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countriesEduardo Edelman Saul, Raquel B. Guerra, Michelle Edelman Saul, Laercio Lopes da Silva, Gabriel F. P. Aleixo, Raquel M. K. Matuda & Gilberto Lopes, Nature Cancer, 11/30/2020
- Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysisR. Park, L. Lopes & A. Saeed, Clinical and Translational Oncology, 3/16/2020
Press Mentions
The Challenges of Implementing Low-Dose Computed Tomography for Lung Cancer Screening in Low- and Middle-Income CountriesNovember 30th, 2020
Professional Memberships
- Member
- Member
- Member
Other Languages
- Portuguese, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
